Walgreens Boots Alliance (WBA) Tops Q4 EPS by 3c; offers FY25 guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Walgreens Boosts Alliance (WBA) PT Raised to $10 at Leerink Partners
October 16, 2024 6:53 AM EDTLeerink Partners analyst Michael Cherny raised the price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $10.00 (from $9.00) while maintaining a Market Perform rating.
The analyst comments "Bottom Line: With a fairly low bar and incredible negative sentiment, WBA's FY4Q'24 results/FY25 guide being less bad turned out to be a... More
BofA Securities Reiterates Underperform Rating on Walgreens Boosts Alliance (WBA)
October 16, 2024 6:24 AM EDTBofA Securities analyst Allen Lutz reiterated an Underperform rating and $7.50 price target on Walgreens Boosts Alliance (NASDAQ: WBA)
The analyst comments "Walgreens is doing what it can to stabilize U.S. Retail Pharmacy profit. This includes closing stores, negotiating more aggressively with... More
Walgreens Boosts Alliance (WBA) PT Lowered to $10 at Deutsche Bank
October 16, 2024 6:18 AM EDTDeutsche Bank analyst George Hill lowered the price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $10.00 (from $11.00) while maintaining a Hold rating.
The analyst comments "Initial 2025 Guide Could Prove to Be a Reach: WBA reported a modest FQ4 beat, and relatively weak F2025 guidance to relatively low expectations, which... More

